Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aparna Mukherjee

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Expert Opinion on Pharmacotherapy|August 30, 2017
Current therapies for the treatment of multidrug-resistant tuberculosis in children in IndiaAparna Mukherjee, Rakesh Lodha, Sushil Kumar Kabra
Indian Journal of Pediatrics|March 28, 2019
Pharmacokinetics of First-Line Anti-Tubercular DrugsAparna Mukherjee, Rakesh Lodha, S K Kabra
Indian Journal of Pediatrics|June 10, 2010
Quality of life and psychosocial functioning of HIV infected childrenSebi Das, Aparna Mukherjee, Rakesh Lodha, et al.
Indian Journal of Pediatrics|December 2, 2021
Antibiotic Stewardship Practices and Prescribing Patterns Across Indian PICUsArpita Chattopadhyay, Aparna Mukherjee, S K Kabra, et al.
The Indian Journal of Medical Research|November 8, 2024
Navigating investigator-initiated clinical trials: A call for guidelines & monitoring frameworks from an Indian contextGunjan Kumar, Jerin Jose Cherian, Roli Mathur, et al.
Indian Journal of Pediatrics|May 27, 2024
Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis of Second-Line Anti-Tubercular Drugs in Indian Children with Multi-Drug ResistanceAparna Mukherjee, Lakshminarayanan Gowtham, Sushil Kumar Kabra, et al.
Indian Journal of Pediatrics|September 4, 2015
Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral TherapyAnirban Mandal, Aparna Mukherjee, R Lakshmy, et al.
BMJ (Clinical Research Ed.)|October 23, 2020
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)Anup Agarwal, Aparna Mukherjee, Gunjan Kumar, et al.
BMC Infectious Diseases|April 19, 2015
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian childrenAparna Mukherjee, Thirumurthy Velpandian, Mohit Singla, et al.
Indian Journal of Pediatrics|June 28, 2018
Pulmonary Hemorrhage in Children: Etiology, Clinical Profile and OutcomeChanna de Silva, Aparna Mukherjee, Kana Ram Jat, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Expert Opinion on Pharmacotherapy|August 30, 2017
Current therapies for the treatment of multidrug-resistant tuberculosis in children in IndiaAparna Mukherjee, Rakesh Lodha, Sushil Kumar Kabra
Indian Journal of Pediatrics|March 28, 2019
Pharmacokinetics of First-Line Anti-Tubercular DrugsAparna Mukherjee, Rakesh Lodha, S K Kabra
Indian Journal of Pediatrics|June 10, 2010
Quality of life and psychosocial functioning of HIV infected childrenSebi Das, Aparna Mukherjee, Rakesh Lodha, et al.
Indian Journal of Pediatrics|December 2, 2021
Antibiotic Stewardship Practices and Prescribing Patterns Across Indian PICUsArpita Chattopadhyay, Aparna Mukherjee, S K Kabra, et al.
The Indian Journal of Medical Research|November 8, 2024
Navigating investigator-initiated clinical trials: A call for guidelines & monitoring frameworks from an Indian contextGunjan Kumar, Jerin Jose Cherian, Roli Mathur, et al.
Indian Journal of Pediatrics|May 27, 2024
Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis of Second-Line Anti-Tubercular Drugs in Indian Children with Multi-Drug ResistanceAparna Mukherjee, Lakshminarayanan Gowtham, Sushil Kumar Kabra, et al.
Indian Journal of Pediatrics|September 4, 2015
Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral TherapyAnirban Mandal, Aparna Mukherjee, R Lakshmy, et al.
BMJ (Clinical Research Ed.)|October 23, 2020
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)Anup Agarwal, Aparna Mukherjee, Gunjan Kumar, et al.
BMC Infectious Diseases|April 19, 2015
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian childrenAparna Mukherjee, Thirumurthy Velpandian, Mohit Singla, et al.
Indian Journal of Pediatrics|June 28, 2018
Pulmonary Hemorrhage in Children: Etiology, Clinical Profile and OutcomeChanna de Silva, Aparna Mukherjee, Kana Ram Jat, et al.
Pageof 11